Physician profile
Peter Mikhail
NPI 1518030535
$2,333.33
in general payments reported to CMS, 2019-2025
16 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $176 · 2021: $14.58 · 2022: $96.34 · 2023: $260 · 2024: $683 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,318.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $673.23 | 2023-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Tosoh Bioscience, INC. | $382.00 | 2019 | |
| Intuitive Surgical, INC. | $223.82 | 2019 | |
| Edwards Lifesciences Corporation | $178.27 | 2024-2025 | Mitris Resilia Mitral Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biom'Up France Sas | $148.23 | 2020 | |
| Abiomed | $131.19 | 2023-2024 | Impella |
| Abbott Laboratories | $131.09 | 2024-2025 | Aveir, Perclose Proglide |
| Bard Peripheral Vascular, INC. | $111.98 | 2022-2024 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Lifestream |
| Novartis Pharmaceuticals Corporation | $106.03 | 2019 | |
| Angiodynamics, INC. | $82.92 | 2022 | |
| Smith+Nephew, INC. | $69.06 | 2024 | Stravix |
| Ethicon US, LLC | $37.35 | 2025 | Dermabond |
| Amarin Pharma, INC. | $15.94 | 2019 | |
| Kls-Martin L.P. | $15.37 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $14.58 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mikhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.